---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "/yy9bZPmbFT22BA1bIn5O54o1cTwyf0v76+vXY502h2dwN01MOPclO1pyFH2t2QIKTkStG0xQNEo49RnBCOra6h5wYBvqC9VcW/ksAawYNjeLdMHvS3kB3f9X4OKtBVX+PtRiMNgHOIWRqU7S6lbavgYgF8TIGVXzwJaXtVHd5hOK6qeMGfQtU88yYoqiyeUtAVduxg52CWc+4iBTTiLhALkN/sHkUHGHnVNGq3VLcMEnMKbPKrKZ6gxTUUii970qlNbD0zVwBDFOxAeoKpY/5M2tO6RX2lYpjiXXRX7FJ8PAEaMhDt7j1ZlCOMCSpR/SwFHCZ5ovS4dxsDht11Szuw+ndV7P4TgrxaxnfxLkYM=;3eiGPV+ShCyd3BX74Cl2TQ=="
---

